ROBYN RUTKIEWICZ: Open Payments
NPI 1447456470 · LATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 26 payments from 12 companies in 2025. Trend: 2023 $755 · 2024 $754 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $191 |
| Novo Nordisk Inc | 3 | $115 |
| ABBVIE INC. | 4 | $74 |
| Exeltis, USA Inc. | 3 | $64 |
| SHIELD THERAPEUTICS INC | 3 | $53 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| CooperSurgical, Inc. | 1 | $38 |
| PFIZER INC. | 1 | $20 |
| Organon LLC | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: ZEPBOUND, Wegovy, LILETTA, SLYND, ACCRUFER, Paragard T 380A, MOUNJARO, MYFEMBREE.
Industry payments across NY — which companies pay providers there.
